Healio (10/30, Demko) reports, “Both prolonged exposure and sertraline showed good short- and long-term efficacy across a range of outcomes among patients with” post-traumatic stress disorder (PTSD), research indicated. What’s more, “patients with PTSD who selected their form of treatment – prolonged exposure or sertraline – showed more improvement than those who were prescribed one or the other regardless of preferences,” the study revealed. The findings of the 200-patient, “doubly randomized preference trial” were published online Oct. 19 in the American Journal of Psychiatry, a publication of the American Psychiatric Association.
Related Links:
— “Patient treatment preference plays role in improving PTSD outcomes, “Savannah Demko, Healio, October 30, 2018.